Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1073

1.

Real-world Safety and Effectiveness of Infliximab in Pediatric Patients With Acute Kawasaki Disease: A Postmarketing Surveillance in Japan (SAKURA Study).

Miura M, Kobayashi T, Igarashi T, Hamada H, Iwata N, Sasaki Y, Matsukawa M, Sato N, Kubo H, Takei S.

Pediatr Infect Dis J. 2020 Jan;39(1):41-47. doi: 10.1097/INF.0000000000002503.

PMID:
31815838
2.

Characteristics and Risk Factors Associated With Diagnosed and Undiagnosed Symptomatic Dry Eye Using a Smartphone Application.

Inomata T, Iwagami M, Nakamura M, Shiang T, Yoshimura Y, Fujimoto K, Okumura Y, Eguchi A, Iwata N, Miura M, Hori S, Hiratsuka Y, Uchino M, Tsubota K, Dana R, Murakami A.

JAMA Ophthalmol. 2019 Nov 27. doi: 10.1001/jamaophthalmol.2019.4815. [Epub ahead of print]

PMID:
31774457
3.

Reliability and validity of the Japanese version of the Ocular Surface Disease Index for dry eye disease.

Midorikawa-Inomata A, Inomata T, Nojiri S, Nakamura M, Iwagami M, Fujimoto K, Okumura Y, Iwata N, Eguchi A, Hasegawa H, Kinouchi H, Murakami A, Kobayashi H.

BMJ Open. 2019 Nov 25;9(11):e033940. doi: 10.1136/bmjopen-2019-033940.

4.

Comparative genetic architectures of schizophrenia in East Asian and European populations.

Lam M, Chen CY, Li Z, Martin AR, Bryois J, Ma X, Gaspar H, Ikeda M, Benyamin B, Brown BC, Liu R, Zhou W, Guan L, Kamatani Y, Kim SW, Kubo M, Kusumawardhani AAAA, Liu CM, Ma H, Periyasamy S, Takahashi A, Xu Z, Yu H, Zhu F; Schizophrenia Working Group of the Psychiatric Genomics Consortium; Indonesia Schizophrenia Consortium; Genetic REsearch on schizophreniA neTwork-China and the Netherlands (GREAT-CN), Chen WJ, Faraone S, Glatt SJ, He L, Hyman SE, Hwu HG, McCarroll SA, Neale BM, Sklar P, Wildenauer DB, Yu X, Zhang D, Mowry BJ, Lee J, Holmans P, Xu S, Sullivan PF, Ripke S, O'Donovan MC, Daly MJ, Qin S, Sham P, Iwata N, Hong KS, Schwab SG, Yue W, Tsuang M, Liu J, Ma X, Kahn RS, Shi Y, Huang H.

Nat Genet. 2019 Dec;51(12):1670-1678. doi: 10.1038/s41588-019-0512-x. Epub 2019 Nov 18.

PMID:
31740837
5.

Rare compound heterozygous missense SPATA7 variations and risk of schizophrenia; whole-exome sequencing in a consanguineous family with affected siblings, follow-up sequencing and a case-control study.

Igeta H, Watanabe Y, Morikawa R, Ikeda M, Otsuka I, Hoya S, Koizumi M, Egawa J, Hishimoto A, Iwata N, Someya T.

Neuropsychiatr Dis Treat. 2019 Aug 19;15:2353-2363. doi: 10.2147/NDT.S218773. eCollection 2019.

6.

A single-nucleotide polymorphism influences brain morphology in drug-naïve patients with major depressive disorder.

Katsuki A, Kakeda S, Watanabe K, Igata R, Otsuka Y, Kishi T, Nguyen L, Ueda I, Iwata N, Korogi Y, Yoshimura R.

Neuropsychiatr Dis Treat. 2019 Aug 23;15:2425-2432. doi: 10.2147/NDT.S204461. eCollection 2019.

7.

Plasma levels of IL-6 in patients with untreated major depressive disorder: comparison with catecholamine metabolites.

Yoshimura R, Kishi T, Iwata N.

Neuropsychiatr Dis Treat. 2019 Sep 13;15:2655-2661. doi: 10.2147/NDT.S195379. eCollection 2019.

8.

Efficacy and safety of blonanserin transdermal patch in patients with schizophrenia: A 6-week randomized, double-blind, placebo-controlled, multicenter study.

Iwata N, Ishigooka J, Kim WH, Yoon BH, Lin SK, Sulaiman AH, Cosca R, Wang L, Suchkov Y, Agarkov A, Watabe K, Matsui T, Sato T, Inoue Y, Higuchi T, Correll CU, Kane JM.

Schizophr Res. 2019 Aug 27. pii: S0920-9964(19)30335-4. doi: 10.1016/j.schres.2019.07.055. [Epub ahead of print]

9.

Polygenic risk scores in schizophrenia with clinically significant copy number variants.

Taniguchi S, Ninomiya K, Kushima I, Saito T, Shimasaki A, Sakusabe T, Momozawa Y, Kubo M, Kamatani Y, Ozaki N, Ikeda M, Iwata N.

Psychiatry Clin Neurosci. 2019 Aug 28. doi: 10.1111/pcn.12926. [Epub ahead of print]

PMID:
31461559
10.

The schizophrenia genetics knowledgebase: a comprehensive update of findings from candidate gene studies.

Liu C, Kanazawa T, Tian Y, Mohamed Saini S, Mancuso S, Mostaid MS, Takahashi A, Zhang D, Zhang F, Yu H, Doo Shin H, Sub Cheong H, Ikeda M, Kubo M, Iwata N, Woo SI, Yue W, Kamatani Y, Shi Y, Li Z, Everall I, Pantelis C, Bousman C.

Transl Psychiatry. 2019 Aug 27;9(1):205. doi: 10.1038/s41398-019-0532-4.

11.

Antidepressant-Like Effect of Ferulic Acid via Promotion of Energy Metabolism Activity.

Sasaki K, Iwata N, Ferdousi F, Isoda H.

Mol Nutr Food Res. 2019 Oct;63(19):e1900327. doi: 10.1002/mnfr.201900327. Epub 2019 Aug 22.

12.

Brexpiprazole as Adjunctive Treatment for Major Depressive Disorder Following Treatment Failure With at Least One Antidepressant in the Current Episode: a Systematic Review and Meta-Analysis.

Kishi T, Sakuma K, Nomura I, Matsuda Y, Mishima K, Iwata N.

Int J Neuropsychopharmacol. 2019 Nov 1;22(11):698-709. doi: 10.1093/ijnp/pyz040.

13.

Light exposure at night and sleep quality in bipolar disorder: The APPLE cohort study.

Esaki Y, Kitajima T, Obayashi K, Saeki K, Fujita K, Iwata N.

J Affect Disord. 2019 Oct 1;257:314-320. doi: 10.1016/j.jad.2019.07.031. Epub 2019 Jul 5.

PMID:
31302520
14.

[Nursing Care Students' Image of Shame -Comparison Between First and Second Year Nursing Students].

Tsuji K, Iwata N, Simojo M, Hagiwara T, Sasaki Y, Nagata Y, Matsumoto M, Kodama H.

J UOEH. 2019;41(2):203-209. doi: 10.7888/juoeh.41.203. Japanese.

15.

Quetiapine extended-release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis.

Kishi T, Ikuta T, Matsuda Y, Iwata N.

Neuropsychopharmacol Rep. 2019 Sep;39(3):256-259. doi: 10.1002/npr2.12070. Epub 2019 Jul 8.

16.

Suvorexant for insomnia in patients with psychiatric disorder: A 1-week, open-label study.

Kishi T, Sakuma K, Okuya M, Ninomiya K, Oya K, Kubo M, Matsui Y, Nomura I, Okuyama Y, Matsunaga S, Iwata N.

Neuropsychopharmacol Rep. 2019 Sep;39(3):252-255. doi: 10.1002/npr2.12069. Epub 2019 Jul 8.

17.

Enhancing laser beam performance by interfering intense laser beamlets.

Morace A, Iwata N, Sentoku Y, Mima K, Arikawa Y, Yogo A, Andreev A, Tosaki S, Vaisseau X, Abe Y, Kojima S, Sakata S, Hata M, Lee S, Matsuo K, Kamitsukasa N, Norimatsu T, Kawanaka J, Tokita S, Miyanaga N, Shiraga H, Sakawa Y, Nakai M, Nishimura H, Azechi H, Fujioka S, Kodama R.

Nat Commun. 2019 Jul 5;10(1):2995. doi: 10.1038/s41467-019-10997-1.

18.

Daytime light exposure in daily life and depressive symptoms in bipolar disorder: A cross-sectional analysis in the APPLE cohort.

Esaki Y, Kitajima T, Obayashi K, Saeki K, Fujita K, Iwata N.

J Psychiatr Res. 2019 Sep;116:151-156. doi: 10.1016/j.jpsychires.2019.06.010. Epub 2019 Jun 17.

PMID:
31247358
19.

COMT polymorphism regulates the hippocampal subfield volumes in first-episode, drug-naive patients with major depressive disorder.

Otsuka Y, Kakeda S, Sugimoto K, Katsuki A, Nguyen LH, Igata R, Watanabe K, Ueda I, Kishi T, Iwata N, Korogi Y, Yoshimura R.

Neuropsychiatr Dis Treat. 2019 Jun 6;15:1537-1545. doi: 10.2147/NDT.S199598. eCollection 2019.

20.

Melatonin receptor agonists-ramelteon and melatonin-for bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials.

Kishi T, Nomura I, Sakuma K, Kitajima T, Mishima K, Iwata N.

Neuropsychiatr Dis Treat. 2019 May 30;15:1479-1486. doi: 10.2147/NDT.S198899. eCollection 2019.

21.

Comparison of quetiapine immediate- and extended-release formulations for bipolar depression: A systematic review and network meta-analysis of double-blind, randomized placebo-controlled trials.

Kishi T, Ikuta T, Sakuma K, Matsuda Y, Iwata N.

J Psychiatr Res. 2019 Aug;115:121-128. doi: 10.1016/j.jpsychires.2019.05.020. Epub 2019 May 20.

PMID:
31128502
22.

Aminophospholipids are signal-transducing TREM2 ligands on apoptotic cells.

Shirotani K, Hori Y, Yoshizaki R, Higuchi E, Colonna M, Saito T, Hashimoto S, Saito T, Saido TC, Iwata N.

Sci Rep. 2019 May 17;9(1):7508. doi: 10.1038/s41598-019-43535-6.

23.

GWAS of smoking behaviour in 165,436 Japanese people reveals seven new loci and shared genetic architecture.

Matoba N, Akiyama M, Ishigaki K, Kanai M, Takahashi A, Momozawa Y, Ikegawa S, Ikeda M, Iwata N, Hirata M, Matsuda K, Kubo M, Okada Y, Kamatani Y.

Nat Hum Behav. 2019 May;3(5):471-477. doi: 10.1038/s41562-019-0557-y. Epub 2019 Mar 25.

PMID:
31089300
24.

Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study.

Hara R, Umebayashi H, Takei S, Okamoto N, Iwata N, Yamasaki Y, Nakagishi Y, Kizawa T, Kobayashi I, Imagawa T, Kinjo N, Amano N, Takahashi Y, Mori M, Itoh Y, Yokota S.

Pediatr Rheumatol Online J. 2019 Apr 30;17(1):17. doi: 10.1186/s12969-019-0319-4.

25.

Efficacy and safety of lithium and lamotrigine for the maintenance treatment of clinically stable patients with bipolar disorder: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials with an enrichment design.

Oya K, Sakuma K, Esumi S, Hashimoto Y, Hatano M, Matsuda Y, Matsui Y, Miyake N, Nomura I, Okuya M, Iwata N, Kato M, Hashimoto R, Mishima K, Watanabe N, Kishi T.

Neuropsychopharmacol Rep. 2019 Sep;39(3):241-246. doi: 10.1002/npr2.12056. Epub 2019 Apr 26.

26.

Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology association of Japan (PRAJ).

Yasumura J, Yashiro M, Okamoto N, Shabana K, Umebayashi H, Iwata N, Okura Y, Kubota T, Shimizu M, Tomiita M, Nakagishi Y, Nishimura K, Hara R, Mizuta M, Yasumi T, Yamaide F, Wakiguchi H, Kobayashi M, Mori M.

Pediatr Rheumatol Online J. 2019 Apr 11;17(1):15. doi: 10.1186/s12969-019-0318-5.

27.

Genetic effects on white matter integrity in drug-naive patients with major depressive disorder: a diffusion tensor imaging study of 17 genetic loci associated with depressive symptoms.

Kakeda S, Watanabe K, Katsuki A, Sugimoto K, Ueda I, Igata N, Kishi T, Iwata N, Abe O, Yoshimura R, Korogi Y.

Neuropsychiatr Dis Treat. 2019 Jan 29;15:375-383. doi: 10.2147/NDT.S190268. eCollection 2019.

28.

[The effectiveness of the complete lateral position method in elderly patients with severe dysphagia].

Kudo H, Ide H, Nakabayashi M, Goto T, Wakakuri A, Iwata N, Kuroki Y.

Nihon Ronen Igakkai Zasshi. 2019;56(1):59-66. doi: 10.3143/geriatrics.56.59. Japanese.

29.

Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population.

Suzuki K, Akiyama M, Ishigaki K, Kanai M, Hosoe J, Shojima N, Hozawa A, Kadota A, Kuriki K, Naito M, Tanno K, Ishigaki Y, Hirata M, Matsuda K, Iwata N, Ikeda M, Sawada N, Yamaji T, Iwasaki M, Ikegawa S, Maeda S, Murakami Y, Wakai K, Tsugane S, Sasaki M, Yamamoto M, Okada Y, Kubo M, Kamatani Y, Horikoshi M, Yamauchi T, Kadowaki T.

Nat Genet. 2019 Mar;51(3):379-386. doi: 10.1038/s41588-018-0332-4. Epub 2019 Feb 4.

PMID:
30718926
30.

Genome-wide association study identifies a novel locus associated with psychological distress in the Japanese population.

Koshimizu H, Nogawa S, Asano S, Ikeda M, Iwata N, Takahashi S, Saito K, Miyakawa T.

Transl Psychiatry. 2019 Jan 31;9(1):52. doi: 10.1038/s41398-019-0383-z.

31.

Identification of a serum-based miRNA signature for response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy.

Niwa Y, Yamada S, Sonohara F, Kurimoto K, Hayashi M, Tashiro M, Iwata N, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Kodera Y.

J Transl Med. 2019 Jan 3;17(1):1. doi: 10.1186/s12967-018-1762-6.

32.

Risk Factors for Severe Dry Eye Disease: Crowdsourced Research Using DryEyeRhythm.

Inomata T, Nakamura M, Iwagami M, Shiang T, Yoshimura Y, Fujimoto K, Okumura Y, Eguchi A, Iwata N, Miura M, Hori S, Hiratsuka Y, Uchino M, Tsubota K, Dana R, Murakami A.

Ophthalmology. 2019 May;126(5):766-768. doi: 10.1016/j.ophtha.2018.12.013. Epub 2018 Dec 11. No abstract available.

PMID:
30550734
33.

Response to the Letter from Dr. Jacob Peedicayil.

Sakuma K, Kishi T, Iwata N.

Psychopharmacology (Berl). 2019 Apr;236(4):1403-1404. doi: 10.1007/s00213-018-5143-x. Epub 2018 Dec 5. No abstract available.

PMID:
30519767
34.

Interaction of ovarian steroidogenesis and clock gene expression modulated by bone morphogenetic protein-7 in human granulosa cells.

Nagao S, Iwata N, Soejima Y, Takiguchi T, Aokage T, Kozato Y, Nakano Y, Nada T, Hasegawa T, Otsuka F.

Endocr J. 2019 Feb 28;66(2):157-164. doi: 10.1507/endocrj.EJ18-0423. Epub 2018 Dec 5.

35.

The effects of different periods of co-administration of oral and long-acting injectable aripiprazole: A propensity score analysis.

Hatano M, Kamei H, Takeuchi I, Tozawa K, Makino S, Hanya M, Yamada S, Iwata N.

Hum Psychopharmacol. 2019 Jan;34(1):e2681. doi: 10.1002/hup.2681. Epub 2018 Nov 27.

PMID:
30480343
36.

Memantine treatment for Japanese patients with moderate to severe Alzheimer's disease: a meta-analysis of double-blind, randomized, placebo-controlled trials.

Kishi T, Matsunaga S, Iwata N.

Neuropsychiatr Dis Treat. 2018 Oct 30;14:2915-2922. doi: 10.2147/NDT.S187320. eCollection 2018.

37.

Efficacy, Acceptability, and Safety of Intravenous Immunoglobulin Administration for Mild-To-Moderate Alzheimer's Disease: A Systematic Review and Meta-Analysis.

Okuya M, Matsunaga S, Ikuta T, Kishi T, Iwata N.

J Alzheimers Dis. 2018;66(4):1379-1387. doi: 10.3233/JAD-180888.

PMID:
30452419
38.

Dorsal buttress plate fixation for the treatment of fracture-dislocation of the fifth carpometacarpal joint with avulsion fracture of the hamate: a case report.

Iwata N, Komura S, Hirakawa A, Kanamori S, Masuda T, Ito Y, Akiyama H.

Arch Orthop Trauma Surg. 2019 Jan;139(1):135-139. doi: 10.1007/s00402-018-3072-0. Epub 2018 Nov 9.

PMID:
30413942
39.

Relationship between VEGF-related gene polymorphisms and brain morphology in treatment-naïve patients with first-episode major depressive disorder.

Nguyen L, Kakeda S, Katsuki A, Sugimoto K, Otsuka Y, Ueda I, Igata R, Watanabe K, Kishi T, Iwata N, Korogi Y, Yoshimura R.

Eur Arch Psychiatry Clin Neurosci. 2019 Oct;269(7):785-794. doi: 10.1007/s00406-018-0953-8. Epub 2018 Nov 7.

PMID:
30406404
40.

Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials.

Kishi T, Oya K, Matsui Y, Nomura I, Sakuma K, Okuya M, Matsuda Y, Fujita K, Funahashi T, Yoshimura R, Iwata N.

Neuropsychiatr Dis Treat. 2018 Oct 1;14:2519-2530. doi: 10.2147/NDT.S176676. eCollection 2018.

41.

Pharmacokinetics of mycophenolate mofetil in juvenile patients with autoimmune diseases.

Nakaseko H, Iwata N, Yasuoka R, Kohagura T, Abe N, Kawabe S, Mori M.

Mod Rheumatol. 2019 Nov;29(6):1002-1006. doi: 10.1080/14397595.2018.1532785. Epub 2019 Jan 3.

PMID:
30289014
42.

Prognostic Impact of Portal System Invasion in Pancreatic Cancer Based on Image Classification.

Morimoto D, Yamada S, Murotani K, Sonohara F, Takami H, Suenaga M, Hayashi M, Niwa Y, Tashiro M, Hattori N, Iwata N, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Fujii T, Kodera Y.

Pancreas. 2018 Nov/Dec;47(10):1350-1356. doi: 10.1097/MPA.0000000000001186.

PMID:
30286011
43.

Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect.

Ikeda M, Takahashi A, Kamatani Y, Momozawa Y, Saito T, Kondo K, Shimasaki A, Kawase K, Sakusabe T, Iwayama Y, Toyota T, Wakuda T, Kikuchi M, Kanahara N, Yamamori H, Yasuda Y, Watanabe Y, Hoya S, Aleksic B, Kushima I, Arai H, Takaki M, Hattori K, Kunugi H, Okahisa Y, Ohnuma T, Ozaki N, Someya T, Hashimoto R, Yoshikawa T, Kubo M, Iwata N.

Schizophr Bull. 2019 Jun 18;45(4):824-834. doi: 10.1093/schbul/sby140.

PMID:
30285260
44.

Magnetized fast isochoric laser heating for efficient creation of ultra-high-energy-density states.

Sakata S, Lee S, Morita H, Johzaki T, Sawada H, Iwasa Y, Matsuo K, Law KFF, Yao A, Hata M, Sunahara A, Kojima S, Abe Y, Kishimoto H, Syuhada A, Shiroto T, Morace A, Yogo A, Iwata N, Nakai M, Sakagami H, Ozaki T, Yamanoi K, Norimatsu T, Nakata Y, Tokita S, Miyanaga N, Kawanaka J, Shiraga H, Mima K, Nishimura H, Bailly-Grandvaux M, Santos JJ, Nagatomo H, Azechi H, Kodama R, Arikawa Y, Sentoku Y, Fujioka S.

Nat Commun. 2018 Sep 26;9(1):3937. doi: 10.1038/s41467-018-06173-6.

45.

The efficacy and safety of memantine for the treatment of Alzheimer's disease.

Matsunaga S, Kishi T, Nomura I, Sakuma K, Okuya M, Ikuta T, Iwata N.

Expert Opin Drug Saf. 2018 Oct;17(10):1053-1061. doi: 10.1080/14740338.2018.1524870. Epub 2018 Sep 26. Review.

PMID:
30222469
46.

Comparative Analyses of Copy-Number Variation in Autism Spectrum Disorder and Schizophrenia Reveal Etiological Overlap and Biological Insights.

Kushima I, Aleksic B, Nakatochi M, Shimamura T, Okada T, Uno Y, Morikawa M, Ishizuka K, Shiino T, Kimura H, Arioka Y, Yoshimi A, Takasaki Y, Yu Y, Nakamura Y, Yamamoto M, Iidaka T, Iritani S, Inada T, Ogawa N, Shishido E, Torii Y, Kawano N, Omura Y, Yoshikawa T, Uchiyama T, Yamamoto T, Ikeda M, Hashimoto R, Yamamori H, Yasuda Y, Someya T, Watanabe Y, Egawa J, Nunokawa A, Itokawa M, Arai M, Miyashita M, Kobori A, Suzuki M, Takahashi T, Usami M, Kodaira M, Watanabe K, Sasaki T, Kuwabara H, Tochigi M, Nishimura F, Yamasue H, Eriguchi Y, Benner S, Kojima M, Yassin W, Munesue T, Yokoyama S, Kimura R, Funabiki Y, Kosaka H, Ishitobi M, Ohmori T, Numata S, Yoshikawa T, Toyota T, Yamakawa K, Suzuki T, Inoue Y, Nakaoka K, Goto YI, Inagaki M, Hashimoto N, Kusumi I, Son S, Murai T, Ikegame T, Okada N, Kasai K, Kunimoto S, Mori D, Iwata N, Ozaki N.

Cell Rep. 2018 Sep 11;24(11):2838-2856. doi: 10.1016/j.celrep.2018.08.022.

47.

Expanding clinical spectrum of autosomal dominant pyrin-associated autoinflammatory disorder caused by the heterozygous MEFV p.Thr577Asn variant.

Nakaseko H, Iwata N, Izawa K, Shibata H, Yasuoka R, Kohagura T, Abe N, Kawabe S, Nishikomori R.

Rheumatology (Oxford). 2019 Jan 1;58(1):182-184. doi: 10.1093/rheumatology/key283. No abstract available.

PMID:
30203097
48.

Clinical practice guidance for juvenile idiopathic arthritis (JIA) 2018.

Okamoto N, Yokota S, Takei S, Okura Y, Kubota T, Shimizu M, Nozawa T, Iwata N, Umebayashi H, Kinjo N, Kunishima T, Yasumura J, Mori M.

Mod Rheumatol. 2019 Jan;29(1):41-59. doi: 10.1080/14397595.2018.1514724. Epub 2018 Oct 29.

PMID:
30126298
49.

Clinical subsets of juvenile dermatomyositis classified by myositis-specific autoantibodies: Experience at a single center in Japan.

Iwata N, Nakaseko H, Kohagura T, Yasuoka R, Abe N, Kawabe S, Sugiura S, Muro Y.

Mod Rheumatol. 2019 Sep;29(5):802-807. doi: 10.1080/14397595.2018.1511025. Epub 2018 Sep 10.

PMID:
30092736
50.

Comparison of the Survival Outcomes of Pancreatic Cancer and Intraductal Papillary Mucinous Neoplasms.

Yamada S, Fujii T, Hirakawa A, Takami H, Suenaga M, Hayashi M, Niwa Y, Hattori N, Iwata N, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Kodera Y.

Pancreas. 2018 Sep;47(8):974-979. doi: 10.1097/MPA.0000000000001110.

PMID:
30028445

Supplemental Content

Support Center